Halozyme Therapeutics to Participate in Upcoming Investor Conference

Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies will be presenting at the 2018 Cantor Global Healthcare Conference in New York on Monday, October 1 at 3:30 p.m. ET/12:30 p.m. PT. Dr Helen Torley, president and chief executive officer, will provide a corporate overview. A live audio webcast of the presentation will be available in the Investors section of Halozyme’s website at www.halozyme.com with an archived replay available for 90 days following the event. – Medical Buyer Bureau